Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference11 articles.
1. Diabetes and cardiovascular disease. The Framingham study;Kannel;JAMA,1979
2. Diabetes and hypertension;Lago;Nat Clin Pract Endocrinol Metab,2007
3. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines;Grundy;Circulation,2004
4. 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;J Hypertens,2007
5. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;J Hypertens,2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application of fixed combinations in the treatment of arterial hypertension. Focus on ramipril and amlodipine;Glavvrač (Chief Medical Officer);2023-06-27
2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10
3. Mechanistic Considerations About an Unexpected Ramipril Drug‐Drug Interaction in the Development of a Triple Fixed‐Dose Combination Product Containing Ramipril, Amlodipine, and Atorvastatin;Clinical Pharmacology in Drug Development;2021-03-27
4. Smart UV spectrophotometric methods based on simple mathematical filtration for the simultaneous determination of celecoxib and ramipril in their pharmaceutical mixtures with amlodipine: A comparative statistical study;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2021-01
5. Drug adjustment of modified risk factors as one of the leading strategies for managing patients with cardiovascular diseases;Medical Council;2020-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3